The Clorox Company agreed on 22 January to acquire GOJO Industries, the Akron, Ohio-based maker of Purell, for $2.25bn in cash including anticipated tax benefits, a net price of $1.92bn.
Why The Clorox Company is buying GOJO Industries, Inc.
Clorox said the deal expands its health and hygiene business into skin hygiene and scales its Health and Wellness segment. GOJO's installed base of about 20 million soap and sanitiser dispensers generates recurring demand, and Purell holds the number one share in hand sanitiser in both business-to-business and retail channels. Clorox expects the deal to support its 3% to 5% long-term sales growth target.
“This is a compelling acquisition that evolves our portfolio”
Deal terms and financing
The headline price includes tax benefits valued at about $330m. Clorox is funding the purchase primarily with debt and expects at least $50m in run-rate cost synergies, with the deal neutral to adjusted EBITDA margin in the first year and accretive after synergies.
Regulatory approvals and timing
Closing was expected before the end of Clorox's fiscal 2026, subject to regulatory approval. Clorox announced completion on 1 April 2026; the business now operates as Clorox Purell, led by Carey Jaros and still based in Akron.
Market context
GOJO was founded in 1946 by Goldie and Jerry Lippman and was run for three generations by the Lippman Kanfer family. It has grown to nearly $800m in annual sales, with a three-year sales growth rate of 5%.
